Every 8-K that Suja Life, Inc. (SUJA) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow SUJA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SUJA filings page.
Suja Life, Inc. (SUJA) entered into an Amended and Restated Credit Agreement on August 20, 2026, through certain indirect subsidiaries with JPMorgan Chase Bank, N.A. as administrative agent, replacing its prior 2021 credit agreement without taking on additional debt. The principal change is a reduction in the borrowing spread, directly lowering the company’s cost of capital.
Under the new agreement, the interest rate is the Term SOFR Rate plus 1.75%, 2.00%, or 2.25% per annum, depending on Suja Life’s consolidated net leverage ratio. The company states that, as a result of this refinancing, it expects its 2026 total interest expense to be $18.0 million, improving available cash flow. Management highlights that the refinancing reflects lender confidence in the consistency of the company’s cash flow generation.
Suja Life, Inc. reported second quarter 2026 net sales of $83.9 million, up 11.6% from $75.2 million, driven by volume growth and new product distribution. Suja Core net sales rose 9.8% to $81.9 million and Emerging Brands grew 61.2% to $3.0 million. Gross margin was 46.7% versus 47.4% a year earlier.
The company recorded a net loss of $27.8 million, a net loss margin of 33.2%, compared with a $5.7 million net loss and 7.5% margin, largely reflecting $25.1 million of one-time IPO-related transaction costs and a $2.3 million loss on debt extinguishment. Adjusted EBITDA increased 50.0% to $14.6 million, a 17.5% margin, compared with $9.8 million and a 13.0% margin in the prior-year quarter.
As of June 29, 2026, cash was $20.6 million and total debt was $163.0 million, down from $303.9 million as of December 29, 2025. For fiscal 2026, Suja Life now expects net sales of $360 million to $369 million and Adjusted EBITDA of $70 million to $72 million, both above fiscal 2025 levels.
Suja Life, Inc. reported a strong first quarter for 2026, with net sales rising 22.5% to $107.1 million from $87.4 million and gross margin improving to 50.5% from 49.8%.
The company swung to net income of $7.7 million, or 7.2% of net sales, from a net loss of $0.8 million. Adjusted EBITDA increased 66.3% to $25.0 million, giving an Adjusted EBITDA margin of 23.4% versus 17.2% a year earlier.
Suja also highlighted its recent IPO of 8.9 million Class A shares at $21.00 per share, generating about $173.6 million in proceeds and enabling repayment of term debt to $164.9 million. For full-year 2026, it expects net sales of $367–$371 million and Adjusted EBITDA of $70–$72 million, along with a projected 27.4% effective tax rate and about $19.0 million in net interest expense.